dr. mehta on the evolution of treatment in gastric and gej cancers
Published 4 years ago • 145 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
0:58
dr. mehta on the role of biomarkers in gastric cancer
-
1:29
dr. mehta on immunotherapy in gastric/gej cancer
-
1:43
dr. mehta on recent progress made in advanced gastric cancer
-
1:34
dr. mehta on the current treatment paradigm in her2-positive gastric cancer
-
1:18
dr. mehta on rationale for a phase ii trial of tas-102/ramucirumab in gastric/gej cancer
-
1:28
dr. shah on improving the benefit of immunotherapy in gastric/gej cancer
-
59:06
gastric and gej cancers: treatment planning and sequencing in the era of immunotherapy
-
6:50
upfront therapy approaches in gastric/gej cancer
-
5:42
evolving global treatment landscape for gastric cancer
-
3:52
investigating the treatment of patients with gastric or gej cancer with ftd/tpi plus ramucirumab
-
5:16
goals of therapy in metastatic gastric/gej cancer
-
5:39
classification guidelines for gastric/gej cancers
-
1:16
dr. ott on the checkmate-032 study in gastric and gej cancer
-
1:07
dr. smaglo on the future of immunotherapy in gastric cancer
-
5:03
gastric/gej cancer: moving the field forward
-
1:55
dr. ku on combinations and sequencing of treatments for gastric cancer
-
1:07
dr. chau on the tolerability of ramucirumab plus pembrolizumab in gastric/gej cancer
-
5:02
selecting perioperative therapy in gastric/gej cancer
-
1:21
dr. shah on the rationale for the keynote-590 trial in esophageal carcinoma